42 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
18 May 20
Condensed Consolidated Financial Statements
4:30pm
in this update provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected … by reference rate reform if certain criteria are met. The amendments apply only to contracts and hedging relationships that reference LIBOR or another
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
14 Aug 20
Condensed Consolidated Financial Statements
4:23pm
and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met … . The amendments apply only to contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
30 Oct 20
Condensed Consolidated Financial Statements
4:30pm
. The guidance in this update provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions … affected by reference rate reform if certain criteria are met. The amendments apply only to contracts and hedging relationships that reference LIBOR
6-K/A
EX-99.1
ENLV
Enlivex Therapeutics Ltd
13 Oct 20
Condensed Consolidated Financial Statements
9:16am
and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met … . The amendments apply only to contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
20 May 19
Condensed Consolidated Financial Statements
4:15pm
.
To date, we have not engaged in hedging our foreign currency exchange risk. In the future, we may enter into formal currency hedging transactions
6-K
EX-99.2
48qqb7hbp7n95g9mj4
18 May 20
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
3tk2za1
14 Nov 19
Condensed Consolidated Financial Statements
7:30am
6-K
EX-99.2
8he2f8txq8y
26 Jul 19
Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.2
0lbdtxn 87s9vt
14 Aug 20
Condensed Consolidated Financial Statements
4:23pm
6-K
EX-99.2
kg6d6grxjti2tjwxfo
30 Oct 20
Condensed Consolidated Financial Statements
4:30pm
6-K/A
EX-99.2
ypzx4 phqw
13 Oct 20
Condensed Consolidated Financial Statements
9:16am
424B3
8itrn 88ncmmz9une
10 Jul 19
Prospectus supplement
8:18am
6-K
EX-99.1
f3m1fsp5wr s4il4
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-1.1
7np6p7cokb2g28l
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
6-K
EX-1.1
rqeufrsqnawn8 ja
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-99.1
wwq0vy
29 Mar 24
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.4
u3z3mr5k mjcd
27 Mar 19
Securities Purchase Agreement
8:32am
F-3
kfx6lsl0rxbtzf dnm
28 Jun 19
Shelf registration (foreign)
9:48am
6-K
EX-99.1
we76kr to21f
27 May 22
Condensed Consolidated Financial Statements
4:39pm
6-K
EX-99.1
rtuky0kfck8hu
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm